SPL submission deadline nears
This article was originally published in The Tan Sheet
Executive Summary
Beginning June 1, firms must electronically submit to FDA drug listings, establishment registrations for OTC products and labeler codes. The agency will accept paper submissions postmarked only through May 31. After that date, FDA will accept data for OTC and veterinary medicine products only submitted electronically in a Structured Product Labeling format (1"The Tan Sheet" Aug. 28, 2006, p. 12)
You may also be interested in...
Paperless Drug Code System Will Allow OTC Listings On DailyMed
FDA's proposed electronic listing system for national drug codes will help the agency expand its electronic labeling system to include OTC drugs, among other products
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.